Shire Receives Approval of FIRAZYR (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan
Shire Announces FDA Approval of TAKHZYRO (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema
New Drug Application Submitted in Japan for INTUNIV (guanfacine hydrochloride extended release) in Adults with ADHD
China's Mineral Export Ban Reinforces Electric Royalties' Long-Term Strategic Focus on Projects Located in Safer Jurisdictions
Silver47 and Summa Silver Announce Merger to Create a Premier U.S. High Grade Silver Explorer & Developer and C$5 Million Brokered Financing
RUA GOLD Completes the Second Phase of Surface Exploration and Drill Targeting at the Glamorgan Project, New Zealand
